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ABSTRACT 
 
Jackson, Mark Patrick. M.S. Department of Neuroscience, Cell Biology, and Physiology, 
Wright State University, 2015.  The Effect of Scalp Tissue on Current Shunting during 
Anodal transcranial Direct Current Stimulation (tDCS). 
 
 
Transcranial Direct Current Stimulation (tDCS) has been used to treat various mental and 
neurological illnesses.  Rodent models have been used to examine physiological changes 
in the brain after tDCS, as well as to develop safety standards.  However, most animal 
tDCS studies implant an electrode on the brain, potentially altering the path of current 
during stimulation.  Additionally, no studies have been completed specifically examining 
maximum safe anodal tDCS limits, and a pilot study conducted to determine an electrode 
montage to examine biological changes of learning and memory from anodal tDCS 
indicated brain lesion was occurring before a commonly cited lesion threshold of 142.9 
A/m2.  Therefore, the goal of this study was to examine both the effects of anodal tDCS 
and the rodent’s scalp on current shunting during anodal tDCS in vivo. Anodal tDCS was 
applied to the skull of 35 anesthetized male Sprague-Dawley rats for 60 minutes after 
they were divided into groups either receiving stimulation with an electrode on the skull 
or scalp tissue.  Within each skull and scalp electrode placement group, rats were further 
separated into groups by tDCS current intensity (µA) received, which was: sham (n=4), 
150 µA (n=4), 300 µA (n=4), 500 µA (n=3), 1,000 µA (n=4), and 2,500 µA (n=3) for the 
skull electrode placement group.  For the scalp electrode placement groups, only 
stimulations that induced lesion during the skull electrode stimulation were chosen: sham
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 (n=2), 500 µA (n=3), 1,000 µA (n=3), and 2,500 µA (n=3).  Brain lesion was quantified 
using an Olympus BX-63 microscope with Q100 Blue Camera and CellSens software, 
which showed brain lesion during skull electrode placement first occurring at 500 uA, 
having a lesion volume of 0.168 mm3.  At 1,000 µA and 2,500 µA, the average brain 
lesion within groups was 6.363 mm3 and 13.013 mm3, respectively.  Stimulation of the 
scalp showed no brain lesion at any of the stimulation groups, suggesting the scalp tissue 
shunts a portion of the current, and as a result, has different physiological effects on brain 
lesion development. 
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I.  INTRODUCTION 
tDCS: Background 
Transcranial Direct Current Stimulation (tDCS) is a noninvasive method of 
electrical brain stimulation and has been used both clinically and experimentally to treat 
multiple brain disorders and diseases.  Electrical stimulation has been used as a medical 
treatment for a long time; ancient Egyptians and even Plato and Aristotle have recorded 
the benefits of electrical stimulation (Kellaway, 1946).  Modernized forms of electrical 
stimulation began in the early 20th Century, when Electro-convulsion Therapy (ECT) was 
used to treat mental health disorders such as depression (Lehmann, 1965) and 
schizophrenia (Tanowitz, Rappa, & Marchitello, 1959). Eventually, ECT gained a 
negative public reputation as being an unsafe treatment method (Kalayam & Steinhart, 
1981), allowing alternative methods of electrical stimulation, such as tDCS, to be refined.  
Today, tDCS is considered a safe method of treatment despite few studies being 
conducted on the safety of tDCS.  Additionally, in vivo tDCS studies using rodents 
typically attach electrodes to the skull, while human tDCS experiments place the 
electrode on the scalp tissue.  Scalp tissue has been shown to decrease the amount of 
current reaching the brain while also spreading the current to brain regions further away 
from the electrode.  This study indirectly looks at the effects of skin tissue on tDCS 
current by measuring brain lesion with two electrode placement locations: scalp and skull 
tissue.  
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Many scientists have contributed to the development of tDCS, but research really 
began to increase when Nitsche and Paulus (2000) were able to show weak direct 
currents can alter cortical excitability both during and after the stimulation period 
(Nitsche & Paulus, 2000).  These experiments showed tDCS could potentially be a 
viable, safe, and inexpensive option for clinical physicians treating patients with various 
neurological disorders (Dubljevic, Saigle, & Racine, 2014).  Research has since provided 
evidence that tDCS in humans can have positive effects on mental health disorders such 
as major depressive episodes (Meron, Hedger, Garner, & Baldwin, 2015), schizophrenia 
(Agarwal et al., 2013), and bipolar disorder (Pereira Junior Bde et al., 2015) among 
others (Tortella et al., 2015).  In addition to the medical benefits, other researchers have 
provided evidence that tDCS can enhance learning and memory in normal, healthy adults 
(Bennabi et al., 2014).  Despite the multiple benefits seen during tDCS research, less 
work has been done on tDCS safety parameters.    
One safety study was conducted by Liebetanz et al. (2009) using one of the two 
types of tDCS stimulation, cathodal tDCS; the other type of tDCS stimulation is anodal 
tDCS.  The two types of stimulation are determined by which electrode (anode or 
cathode) is placed over the desired stimulation area (Figure 1).  In a tDCS circuit, 
electrons always move in a loop from the cathodal (positively charged) end of a battery, 
through the brain and its extracerebral tissues, then back into the anodal (negatively 
charged) end of the battery (Li & Ke, 2011).  To perform anodal stimulation, the anode is 
placed over the brain region to be stimulated, while cathodal stimulation requires the 
cathode be placed over the brain region.  During anodal stimulation, electrons meet the 
area of interest under the anode after passing through the brain and its extracerebral 
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tissues via the cathode.  Conversely, when using cathodal stimulation, electrons 
immediately flood the area of interest, which then flow to the anode.  Of note, when 
discussing electrical current in general, it is common to discuss the current as flowing in 
the opposite direction of the electrons.  Put more simply, electrons always flow from 
cathode to anode, yet the current is always discussed as flowing from anode to cathode, 
regardless of the orientation of the electrodes (Wagner et al., 2014). 
 
Figure 1: Differences between Anodal and Cathodal tDCS.  Electric currents (solid 
black line) are described as flowing from anode (red electrode) to cathode (blue 
electrode); however, electrons flow (red dashed line) from cathode to anode.  To induce 
anodal stimulation, the anode is placed over the desired area of stimulation.  Conversely, 
the cathode is placed over the area of stimulation for cathodal tDCS. 
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tDCS Today: Neurologic, Mental Health, and Learning/Memory Enhancement 
Today, researchers and clinicians alike use both tDCS stimulations for many 
reasons, ranging from improving function in people with neurological diseases to 
enhancing learning and memory abilities in humans.  In clinical settings, tDCS is used to 
treat a wide variety of neurological diseases, such as stroke (Gomez Palacio Schjetnan, 
Faraji, Metz, Tatsuno, & Luczak, 2013), some types of neuropathy (Kim et al., 2013), 
and Autism deficits (Amatachaya et al., 2014).  Typically, this is done with anodal 
stimulation, although cathodal stimulation benefits have been noted (Monti et al., 2013).  
Regarding stroke, tDCS appears to reduce the severity of signs and symptoms related to 
the damage resulting from a stroke (Baker, Rorden, & Fridriksson, 2010; O'Shea et al., 
2014), although it should be noted tDCS does not entirely diminish or cure the negative 
effects a stroke or other diseases produce.  Pain symptoms resulting from various types of 
neuropathy have also been alleviated with tDCS treatment (Ngernyam, Jensen, 
Auvichayapat, Punjaruk, & Auvichayapat, 2013), and promising benefits of tDCS on 
autism, even years after birth, have also been seen (Amatachaya et al., 2014).   
While clinical benefits for neurological problems are beginning to emerge, most 
tDCS research has been done for relief of various mental health issues.  Mental health 
problems such as depression (Oliveira et al., 2013), bipolar disorder (Pereira Junior Bde 
et al., 2015), and some neurodegenerative diseases (Elder & Taylor, 2014) have all 
responded favorably after tDCS treatment.  Interestingly, tDCS seems to reverse the 
negative effects of most mental illnesses treated, regardless of the symptoms.  For 
example, patients with depression treated with tDCS showed improved depression rating 
scores (Valiengo, Bensenor, Lotufo, Fraguas Jr, & Brunoni, 2013), while patients with 
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Alzheimer’s showed marked improvement in recognition memories after tDCS 
stimulation (Ferrucci et al., 2008). 
In addition to improving memory in patients with Alzheimer’s, tDCS studies 
focusing on improving learning and memory in normal, healthy adults have increased 
(Matzen, Trumbo, Leach, & Leshikar, 2015; Pope, Brenton, & Miall, 2015).   In addition, 
research on tDCS with attention during monotonous tasks has shown marked 
improvement in attention when the subjects were sleep deprived compared to Sham or 
caffeine consumption (McIntire, McKinley, Goodyear, & Nelson, 2014).  In addition to 
attention enhancement, studies on enhancing sports performance with tDCS has shown 
promising results (Zhu et al., 2015), as well as improving fine motor coordination in 
musicians with dystonia (Furuya & Altenmuller, 2015).  The beneficial effects of tDCS 
seen in normal, healthy individuals is an exciting new area of research.  However, 
because tDCS as a whole is a fairly new approach, caution should be exercised before it 
is approved for use on the general public. 
General Issues Moving Forward: Ethics, Stimulation Localization, and Public 
Perception 
From a biochemical perspective, little is known regarding how tDCS actually 
results in changes to the brain’s structure (de Berker, Bikson, & Bestmann, 2013), and 
while studies of tDCS function are beginning to increase, many are being performed on 
humans where inconclusive data prevents researchers from moving to Phases III and IV 
(Brunoni et al., 2012).  This raises issues that tDCS researchers are beginning to address, 
such as safety and efficacy.  To understand how prevalent these concerns are, a survey of 
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tDCS researchers was conducted, and over half of human tDCS first and senior authors 
that participated expressed doubts regarding both the efficacy and ethics of tDCS (Riggall 
et al., 2015).   
Another interesting issue of ethics and tDCS is that only beneficial effects have 
been almost exclusively reported.  Besides minor skin tingling in humans (Fertonani, 
Ferrari, & Miniussi, 2015), there have been very few reported unwanted effects.  One of 
the few negative reports showed potentially cytotoxic calcium levels after repeated 
anodal DC stimulation (Islam, Aftabuddin, Moriwaki, Hattori, & Hori, 1995), 
highlighting the need for an increased understanding of the physiological effects of tDCS.  
To research how tDCS affects the brain, a basic understanding of where the 
current is moving in the brain should be addressed.  Many researchers are studying how 
tDCS flows through the brain using computational models (Galletta et al., 2015; 
Parazzini, Fiocchi, Liorni, & Ravazzani, 2015), but in vivo models have yet to be fully 
utilized.  During tDCS in humans, electrodes are placed on the scalp tissue, which has 
been shown to shunt (disperse the electrical current from the direction it was moving) a 
portion of the current (Faria, Hallett, & Miranda, 2011; Truong, Magerowski, Blackburn, 
Bikson, & Alonso-Alonso, 2013), making it difficult to determine the concentration and 
spread of electrical current reaching the brain in vivo.   
As noted above, less physiological studies of tDCS in vivo have been performed 
compared to clinical studies, and as a result, physiological effects of the stimulation have 
not been adequately addressed.  Also, because clinical studies focus on improving a 
specific issue, public perception has been mostly positive, even though how tDCS 
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actually invokes changes in the brain is less understood.  The lack of negative effects 
from tDCS suggests to the public that tDCS is completely safe, but caution should be 
observed before agreeing with the public’s positive perception of tDCS (Dubljevic et al., 
2014).  Many drugs with no known side effects prescribed to the general public without 
sufficient research have resulted in severe, unpredicted side effects, such as with 
Thalidomide (Miller & Stromland, 2011).  It would be beneficial to all invested in tDCS 
to understand any negative effects, and this would be more safely done utilizing models 
other than humans. 
Computational Modeling and Animal Preparations in tDCS 
There are two common types of models used for tDCS research: computational 
and both in vivo and in vitro animal preparations.  Computational models use existing 
knowledge of how electricity acts on tiny, isolated areas of the brain, such as a neuron, 
and combines that information to predict how the current acts on the brain as a whole 
(Wagner et al., 2014), which is done using different types of computational modeling.  
One common type of computational modeling used in tDCS is Finite Element Modeling 
(FEM), which incorporates mathematical equations into a representative model made of 
materials that represent the brain’s cellular properties (Laakso & Hirata, 2012).  tDCS is 
then applied to the brain model, and different aspects of the current’s effect on the brain 
can be measured (Rush & Driscoll, 1968; Truong et al., 2013). 
FEM is usually studied via computer software, and can involve simple (Faria et 
al., 2011) or complex (Saturnino, Antunes, & Thielscher, 2015) representations of the 
brain and its surrounding tissues.  Additionally, the finite aspects of brain 
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electrodynamics can be combined to create a more homogenous mathematical 
representation to study tDCS effects (Dougherty, Turner, & Vogel, 2014).  These models 
are invaluable to tDCS research, but the greatest understanding of tDCS current can be 
realized when computational modeling is combined with animal preparations. 
Animal preparations are the other commonly used method of tDCS research, with 
the rodent (mouse and rat) being a common type of animal used (Bennabi et al., 2014; 
Bolzoni, Baczyk, & Jankowska, 2013).  Utilizing animals can be a powerful tool for 
testing in vivo effects of tDCS, however, as with most animal preparations, there are 
some limitations for translating animal research findings to human physiology.  Despite 
the limitations when using animals to test the effects of tDCS, a great amount of insight 
has been gained to the underlying neural mechanisms affected by tDCS (Pedron, Monnin, 
Haffen, Sechter, & Van Waes, 2014; Rahman et al., 2013).  However, there are some 
differences when delivering a tDCS current in humans that are not used with rodents, one 
of which being the electrode montage used. 
Translational Considerations: Electrode, Montage, and Tissue 
 There are many different types of electrodes available for tDCS (Bolzoni, 
Pettersson, & Jankowska, 2013; McIntire et al., 2014; Pedron et al., 2014), and each type 
of electrode is constructed using different materials.  Using only one type of electrode 
could stunt progress, but the variations make choosing an electrode for tDCS more 
difficult because different electrodes have different conductive properties and materials.  
Further, the electrodes used in rodent models are specially designed for rodents 
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(Liebetanz et al., 2006), and are not representative of tDCS electrodes used during 
humans studies. 
Typically, animal studies utilize a type of electrode jacket that is implanted onto 
the skull and filled with a conducting solution that an electrode is then screwed into 
(Liebetanz et al., 2009; Pedron et al., 2014), whereas human studies utilize sponge 
electrodes soaked in a conductive material placed on the scalp (DaSilva, Volz, Bikson, & 
Fregni, 2011).  In addition, different electrode montages are beginning to be explored, 
such as the newly emerging HD-tDCS. This high definition electrode montage has been 
suggested to improve the localization of stimulation (DaSilva et al., 2015), and is 
beginning to be used in humans.  
 Another issue limiting animal translation is the effect electrode placement has on 
electrical currents in the brain.  This problem arises due to differences in head size 
between rodents and humans (Takano et al., 2011).  The distance between anode and 
cathode has been shown to affect how the current travels (Faria et al., 2011), ultimately 
dictating which regions of the brain a current reaches.  A smaller distance between anode 
and cathode has been shown to increase the amount of current shunting, resulting in a less 
focused current distribution during stimulation (Datta, Elwassif, Battaglia, & Bikson, 
2008; Faria et al., 2011; Rush & Driscoll, 1968).  Further, placing both electrodes on the 
head results in both anodal and cathodal stimulation, termed bilateral stimulation.  
Bilateral stimulation can have undesired effects in human tDCS if the montage was not 
intended, and using bilateral tDCS would be difficult to replicate on rodents due to head 
size constraints.  
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Another component to consider when choosing an electrode montage is the 
orientation of neurons at the stimulation site.  Computational research has shown when 
the current is directed downward to a neuron, an effect will occur; if the current is 
directed to the side of a neuron, however, a different effect occurs.  Additionally, other 
effects are seen when a tDCS current hits a neuron at other angles (Bikson & Rahman, 
2013; Rahman et al., 2013).  The precise angle a current moves through a neuron cannot 
be known with in vivo models; heads come in different shapes and sizes, but 
computational models can be controlled for different sizes and shapes of individual tissue 
in vivo during stimulation (Truong, Magerowski, Pascual-Leone, Alonso-Alonso, & 
Bikson, 2012), giving insight to how electrodes should be placed in live models.   
 In addition to electrode type and montage, another translational issue to consider 
is where to place the electrode in rodent tDCS, which is generally implanted surgically 
onto the skull to maximize the amount of current reaching the rodent’s brain (Bolzoni, 
Baczyk, et al., 2013; Liebetanz et al., 2006; Liebetanz et al., 2009).  Stimulating with the 
electrode on the skull tissue presents a significant translational inconsistency due to 
human tDCS using scalp electrodes, where most of the electrical current is believed to be 
shunted away from the brain (Faria et al., 2011).  Further, the individual properties of the 
scalp tissue has been shown to affect the portion of the current that does reach the brain 
(Truong et al., 2013), indicating rodent tDCS models are receiving more current in the 
brain region being stimulated.  Using an electrode montage on scalp tissue during rodent 
tDCS would enhance the ability of rodent studies to translate to human physiology during 
tDCS by mimicking the scalps effects.  
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 Liebetanz et al. (2009) studied safe tDCS stimulations in rodents using brain 
lesion during cathodal tDCS at varying intensities to determine the maximum safe dosage 
before lesion was observed.  Currents utilized were between 1 and 1000 µA for 
stimulation durations between 3.33 and 270 minutes with an electrode of 3.5 mm2.   They 
were able to show brain lesion occurs during a cathodal stimulation with a current 
intensity of 500 µA lasting at least 10 minutes, resulting in a current density of 142.9 
A/m2.  Additionally, a current of 1000 µA lasting at least 3.33 minutes also induced 
lesion in the rat.  Furthermore, they showed a correlational relationship between charge 
density [calculated as: (Current Intensity * seconds of stimulation)/electrode size] and 
brain lesion to arrive at a lesion threshold of 54,000 C/m2.  Despite not testing anodal 
tDCS, they suggested the lesion parameters would be very similar to cathodal tDCS 
lesion limits (Liebetanz 2009).   
Conclusion and Hypothesis 
The effects of scalp shunting have not yet been tested in vivo, but from 
computational models studying the effects of scalp tissue on the current during tDCS 
(Faria et al., 2011; Truong et al., 2013), it can be predicted that tDCS using rodents with 
an electrode placed on the scalp will result in less current reaching the brain.  
Additionally, it has been thought that brain lesion would occur at the same current 
density for both anodal and cathodal tDCS (Liebetanz et al., 2009), while others have 
been more conservative regarding safety similarities between the two types of tDCS 
currents due to a lack of anodal tDCS lesion data (Bikson, Datta, & Elwassif, 2009).  
Interestingly, a rodent pilot study performed in our lab was conducted to determine an 
appropriate anodal tDCS montage to study the neurophysiology of learning and memory 
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showed brain lesion occurring at current densities lower than the 142.9 A/m2 threshold 
determined by the Liebetanz et al study. 
Therefore, the purpose of this study was twofold: 1) test the brain lesion threshold 
of 142.9 A/m2 during cathodal tDCS during anodal tDCS in rodents when an electrode is 
implanted on the skull, and 2) indirectly study the decrease in current reaching brain 
tissue from scalp shunting during tDCS by comparing differences between brain lesion 
when the electrode is placed on the skull and scalp.  The results of these experiments 
should enhance our understanding of tDCS safety as well as the ability to use animal 
preparations for translation to human physiological changes resulting from tDCS.
 
13 
Distribution A: Approved for public release; distribution unlimited.   
88ABW Cleared 11/09/2015; 88ABW-2015-5473. 
 
II.  METHODS 
All procedures were approved by the Wright-Patterson Air Force Base (WPAFB) 
Institutional Animal Care and Use Committee (IACUC) and performed in accordance 
with the Guide for the Care and Use of Laboratory Animals (National Research Council, 
2011). The experiments were performed on 35 male Sprague-Dawley rats (Charles River, 
Wilmington, MA), weighing 300-500 grams, and split into two groups by electrode 
placement: skull (n=21) and scalp (n=14).  Animals were double housed under standard 
laboratory conditions, including a 12 hour light/dark cycle with food and water available 
ad libitum.  Following a ten day quarantine/acclimation period, the skull electrode 
stimulation animals underwent surgery to place an electrode on the skull. After surgery, 
animals were singly housed and allowed to recover at least 7 days prior to inclusion in 
any experiments.  Following surgery, animals were randomly placed into six anodal 
tDCS treatment groups: Sham, (n = 3), 150 µA (n = 4), 300 µA mA (n = 4), 500 µA (n = 
2), 1,000 µA (n = 4), and 2,500 µA (n = 3). Scalp stimulation animals were randomly 
placed into 3 anodal tDCS groups that indicated lesion present during stimulation with a 
skull electrode, plus a sham group (n = 4): 500 µA (n = 4), 1,000 µA (n = 3), and 2,500 
µA (n = 3).
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Skull Placement Surgery 
 Animals were anesthetized with isoflurane (Piramal Critical Care, Shop Med Vet, 
Mettawa, IL) using 5% induction and 2-3% maintenance.  Animals were treated with 
standard pre- and post-surgical care, according to WPAFB vivarium IACUC approved 
Standard Operating Procedure’s (SOP’s).  The animal was placed into a stereotaxic 
apparatus and a caudo-rostral incision was made on top of the head, then a lateral incision 
was made at the shoulders.  The periosteum was removed, the skull was wiped clean, and 
a head electrode of  25 mm2 (ValuTrode, Axelgaard Manufacturing Co., Fallbrook, CA, 
1.25 inch diameter electrode cut  to 5mm x 5mm) was applied to the skull with the center 
of the electrode resting on the midline 2.5 mm caudal to bregma (rostrocaudal: 0.0 mm to 
-5.0 mm).  The insulated electrode wire was tunneled subcutaneously and exited the 
incision made at shoulders.  The electrode was held in place by a plastic head clamp 
which caught on the ridges of the skull (AFRL designed and produced) and two types of 
adhesives.  C&B Metabond Adhesive Luting Cement (Parkell Inc., Edgewood, NY) was 
applied to the electrode and skull to create an initial bond, followed by acrylic cement 
(Stoelting, Co. Fisher Scientific, Pittsburg, PA) to bond the electrode to the clamp.  
Incisions were then closed around cement and wire by suture.  Animals recovered from 
surgery for at least 1 week prior to inclusion in experiments. 
tDCS Treatment 
   Animals were anesthetized with isoflurane (Piramal Critical Care, Shop Med 
Vet, Mettawa, IL), using a 5% induction and 2-3% maintenance schedule. The reference 
electrode (8.04 cm2, ValuTrode, Axelgaard Manufacturing Co., Fallbrook, CA) was 
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placed between the shoulders and Signagel electrode gel (Parker Laboratories, Fairfield, 
NJ) was used as the conductor.  A Petflex cohesive bandage (Andover, Shop Med Vet, 
Mettawa, IL) was wrapped around the midsection of the animal’s torso to hold the 
reference electrode in place.  tDCS was applied using a constant current stimulator 
(Magstim DC-stimulator, Neuroconn, Ilmenau, Germany) for 60 minutes.  The animals 
receiving sham stimulation were also anesthetized, had the reference electrode placed, 
and had wires connected to the electrodes, but no current was passed through the 
electrodes.  During skull stimulation, the animals that received the highest dose of 
stimulation received tDCS at the highest level that the stimulator could provide based on 
the voltage limitations (5,000 µA).  Throughout the highest intensity stimulation, the 
stimulator automatically shut off when the resistance limit was reached.  Following the 
automated shut down, the device was restarted and stimulation resumed at a lower 
intensity level.  The total duration remained at 60 minutes, but the intensity varied during 
stimulation from 5,000 µA to 2,000 µA for the highest intensity group.  The average 
intensity for the 60 minute duration for this group was 2,500 µA and is referred to as the 
2,500 µA condition throughout this manuscript.  During scalp stimulation, the highest 
stimulation received was 2,500 µA and was decreased by 500 µA if the voltage limit was 
reached; it is also referred to as the 2,500 µA group. 
Histological Processing and Analysis 
Immediately following the cessation of stimulation, animals were euthanized by 
Euthasol injection followed by exsanguination; tissue was fixed and preserved using 
intracardiac perfusion using PBS followed by 4% paraformaldehyde was completed.  
After perfusion, brains were removed and placed into a 4% PFA solution for twenty-four 
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hours then transferred to a 30% sucrose solution for two days until the brains sank. Brains 
were kept in solution at 4o C until processed.  A sliding microtome with a freezing plate 
(Leica SM2010R) was used for serial collection of 16-micron thick sections across the 
brain.  Slices were placed into a cryoprotectant solution and stored at -20 º C until further 
processing. 
H&E Staining 
Two sets of brain sections from each animal were removed from cryoprotectant 
solution, washed 5 times for 5 min each in 1X PBS and mounted onto slides using a 0.1X 
PB solution with 5% gelatin. Tissue sections were stained with hematoxylin and eosin 
(H&E), and images were collected after staining using an Olympus BX63 microscope 
with a camera (Blue Camera) designed for CellSens Dimension software.  
Image and Data Analysis 
 Researchers quantifying lesion were blinded to treatment groups throughout tissue 
processing, image collection, and analysis.  Individual tissue sections from each animal 
were placed in rostral-caudal (all tissues were within a range of +5mm Bregma and -6.5 
mm Bregma) order using a Stereotaxic Rat Atlas (Paxinos & Watson, 2007), then the 
area of brain lesion was quantified for each tissue section using CellSens software.  All 
sections fell within a range of +5 mm Bregma and -6.5 mm Bregma, and 0.5 mm 
increments were chosen as data points to ensure a uniform reporting method along the 
entire range.   
Tissue sections were then averaged to each 0.5 mm increment if they were within 
0.4 mm of that data point.  The lesion area of each tissue section was averaged together at 
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its assigned increment, and the sum of all increments gave a total lesion area for each 
animal.  Lesion volume was determined by multiplying the average area at each 
increment by 0.5 mm.  The tDCS current applied to each animal was quantified in 
multiple ways using the following measurements: current (I), current density (I/mm2), 
charge density ((I*t)/mm2), and Joules (I2Rt), where I is represented in Amperes (A), 
mm2 represents the surface area of the electrode used, t represents time (sec), and R 
represents the resistance during the stimulation (ohms).
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III. RESULTS 
Skull Electrode tDCS Results 
Tissue sections were analyzed for areas of brain lesion by comparing stimulated 
tissues to the Sham condition.  Neither the Sham, 150 µA, nor 300 µA groups showed 
brain lesion, while the 500 µA, 1,000 µA, and 2,500 µA stimulation groups did have 
lesions present (Figure 2).  The 500 µA group shows a small discoloration at the medial 
cortex area that does not penetrate deeper than the outer surface of the rat cortex (Fig. 
2B).  Compared to the 500 µA group, the 1,000 µA group’s discoloration penetrates 
further into the cortex and spreads laterally across the outer cortex (Fig. 2C).  The 2,500 
µA stimulation group appears to have the greatest area of brain tissue lesion, but the 
discoloration did not penetrate past cortical brain regions (Fig. 2D). 
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Figure 2: tDCS-induced brain lesion near -2.5 mm Bregma.  Increasing tDCS current 
increases brain lesion in the rat compared to the Sham (A).  A 500 µA current (B) 
induces brain lesion beginning in the medial outer cortex, which spreads laterally and 
penetrates into the cortex as the current is doubled to 1,000 µA (C).  This lesion expands 
laterally and deeper into the cortex when the current is increased to 2,500 µA (D).  The 
black arrowheads indicate areas of lesion. 
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Brain lesion was quantified for all animals by measuring and averaging the 
volume of brain tissue damage for each stimulation group (Figure 3).  Brain damage was 
present at 500 µA (average volume = 0.168 mm3, SE = 0.105), 1,000 µA (average 
volume = 6.363 mm3, SE = 1.104), and 2,500 µA (average volume = 13.013 mm3, SE = 
1.068) (Fig. 3B).   
A one sample t test was performed to compare lesions within stimulation groups 
to their sample means, which showed no significant differences (Fig. 3A).  Using a one 
way ANOVA, the 2,500 µA stimulation group had a significant volume of lesion 
compared to all other groups (p < 0.001 for all stimulation group comparisons) groups.  
Similarly, the 1,000 µA stimulation group had a significant difference compared to all 
other groups (p < 0.001 for all stimulation group comparisons) (Fig. 3B).  There were no 
other significant differences when comparing the Sham, 150 µA, 300 µA, or 500 µA 
groups (Fig. 3B).  
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Figure 3: Individual and group lesion quantification.  Lesion area was quantified in 
H&E stained sections obtained from all animals (A) at each stimulation group after tDCS 
with an electrode implanted on the skull.  Average lesion volume was also quantified for 
each stimulation group (B).  In both figures, no lesion was present at currents less than 
500 µA, but lesion was seen at currents of 500 µA and greater. * indicates the 2,500 µA 
group had significant differences from all other stimulation groups.  # indicates the 1,000 
µA group had significant differences from all other stimulation groups. 
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Average brain lesion per tissue section was also analyzed via a two-way ANOVA 
followed by a Tukey test. (Figure 4).  After correcting the p-value for multiple 
comparisons, no significant differences between stimulation groups appeared until +2 
mm Bregma, which occurred between stimulation groups until -6.5 Bregma and are 
detailed in Table 1.  Briefly, significant lesion differences between 2,500 µA and 500 µA 
stimulation groups were seen from +2 mm Bregma to -5.5 mm Bregma, and between 
2,500 µA and 1,000 µA stimulation groups (p < 0.01 for all), significant differences 
range from +0.5 mm Bregma to -5.5 mm Bregma (p < 0.05 for all).  Significant 
differences range from +2 mm Bregma to -5 mm Bregma between 1,000 µA and 500 µA 
stimulation groups (p < 0.02). 
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Figure 4: Average lesion area by brain tissue section.  The average brain lesion was 
quantified in 0.5 mm increments, with positive numbers indicating the distance rostral to 
Bregma, and negative numbers indicating the distance caudal to Bregma.  The black line 
at the bottom of the figure indicates the location of the electrode.  Significant lesion 
differences between the lesion inducing currents are indicated at the top of the figure.  
The bars at each tissue section represent the Standard Error for each stimulation group.  
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Significant Tissue Section Lesion Differences 
Mean Difference (mm2), p-value 
Tissue Section 2,500 µA vs. 500 µA 2,500 µA vs. 1,000 µA 1,000 µA vs. 500 µA 
+2 mm Bregma 0.911, < 0.005 - 0.805, < 0.008 
+1.5 mm Bregma 1.217, < 0.001 - 1.058, < 0.001 
+1 mm Bregma 1.615, < 0.001 - 1.075, < 0.001 
+0.5 mm Bregma 1.967, < 0.001 0.777, < 0.011 1.190, < 0.001 
0 mm Bregma 2.305, < 0.001 1.212, < 0.001 1.093, < 0.001 
-0.5 mm Bregma 2.624, < 0.001 1.710, < 0.001 0.915, < 0.003 
-1 mm Bregma 2.685, < 0.001 1.745, < 0.001 0.940, < 0.002 
-1.5 mm Bregma 3.195, < 0.001 2.277, < 0.001 0.918, < 0.003 
-2 mm Bregma 3.059, < 0.001 2.208, < 0.001 0.851, < 0.005 
-2.5 mm Bregma 2.989, < 0.001 2.179, < 0.001 0.810, < 0.007 
-3 mm Bregma 2.922, < 0.001 2.030, < 0.001 0.892, < 0.003 
-3.5 mm Bregma 2.638, < 0.001 1.694, < 0.001 0.944, < 0.002 
-4 mm Bregma 2.368, < 0.001 1.496, < 0.001 0.872, < 0.004 
-4.5 mm Bregma 2.584, < 0.001 1.943, < 0.001 0.641, < 0.05  
-5 mm Bregma 2.001, < 0.001 1.579, < 0.001 - 
-5.5 mm Bregma 1.730, < 0.001 1.551, < 0.001 - 
-6 mm Bregma 1.438, < 0.001 1.323, < 0.001  - 
-6.5 mm Bregma 0.791, < 0.017 0.717, < 0.020  - 
 
Table 1: Specific mean lesion area differences between lesion-inducing currents for each 
tissue section.  For each comparison, the average difference in mm2 is noted first, 
followed by the corresponding p-value.  The black boxes indicate no significant 
differences at the tissue section for the comparison.     
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Scalp Electrode tDCS Results 
Histological analysis of the animals receiving tDCS with the electrode placed on 
the scalp was performed, and no lesion resulting from anodal tDCS was noted (Figure 5).  
Further histological analysis did not show tDCS-induced lesion at any tissue section 
(Figure 6).  
 
Figure 5: Images of brain tissue located near -2.50 mm Bregma after tDCS with an 
electrode implanted on the scalp.  The three stimulation groups are compared to the 
Sham (A).  For all three stimulation groups, no brain lesion was seen at 500 µA (B), 
1,000 µA (C), or 2,500 µA (D). 
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Figure 6: Lesion area by tissue section after tDCS with an electrode implanted on the 
scalp.  No lesion was noted at any tissue section for any of the stimulation groups.  The 
black line at the bottom of the figure indicates the placement of the electrode.  
 
Electrode Placement Comparison: Skull vs. Scalp 
Lesion results from each tested stimulation group were compared for significant 
differences between scalp and skull electrode placement.  A three-way ANOVA 
(corrected for multiple comparisons) was performed to compare the effects of electrode 
placement, tissue section, and stimulation intensity to lesion.  Significant differences in 
lesion from electrode placement on the scalp and skull at each tissue section are as 
follows: p < 0.001 from +2 mm Bregma to -5.5 mm Bregma for the 2,500 µA stimulation 
group, and p < 0.001 from +2 mm Bregma to -4.5 mm Bregma for the 1,000 µA 
stimulation group.  There were no significant differences between scalp and skull 
electrode placement for the 500 µA group (Figure 7).  Specific lesion differences 
between scalp and skull electrode placement during tDCS are shown in Table 2. 
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Figure 7: A lesion comparison between an electrode implanted on the skull and an 
electrode placed on the scalp within each stimulation group.  The solid black line at the 
bottom indicates the position of the electrode, and the bars at the top reflect the 
significant differences between lesion at each tissue section, mm, from tDCS with an 
electrode placed on the scalp and an electrode placed on the skull.  Significant 
differences are detailed in Table 2. 
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Skull vs. Scalp Electrode Placement 
Mean Difference (mm2), p-value 
Tissue Section 2,500 µA 1,000 µA 500 µA 
2 mm Bregma 0.911, < 0.001 0.805, < 0.001 - 
1.5 mm Bregma 1.217, < 0.001 1.058, < 0.001 - 
1 mm Bregma 1.628, < 0.001 1.089, < 0.001 - 
0.5 mm Bregma 1.990, < 0.001 1.214, < 0.001 - 
0 mm Bregma 2.321, < 0.001 1.109, < 0.001 - 
-0.5 mm Bregma 2.643, < 0.001 0.934, < 0.001 - 
-1 mm Bregma 2.714, < 0.001 0.969, < 0.001 - 
-1.5 mm Bregma 3.234, < 0.001 0.957, < 0.001 - 
-2 mm Bregma 3.103, < 0.001 0.895, < 0.001 - 
-2.5 mm Bregma 3.041, < 0.001 0.863, < 0.001 - 
-3 mm Bregma 2.967, < 0.001 0.936, < 0.001 - 
-3.5 mm Bregma 2.697, < 0.001 1.004, < 0.001 - 
-4 mm Bregma 2.449, < 0.001 0.953, < 0.001 - 
-4.5 mm Bregma 2.636, < 0.001 0.693, < 0.001 - 
-5 mm Bregma 2.023, < 0.001 - - 
-5.5 mm Bregma 1.735, < 0.001 - - 
-6 mm Bregma 1.438, < 0.001 - - 
-6.5 mm Bregma 0.791, < 0.001 - - 
 
Table 2: Significant differences between skull and scalp electrode placement.  
Differences between the average lesion at each tissue section are reported.  Boxes with 
dashes represent no significant differences between skull and scalp electrode placement 
at that tissue section. 
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IV.  DISCUSSION 
These experiments show anodal tDCS produces lesion on the rodent brain at a 
current intensity of 500 µA and above when the electrode is placed on the skull, while 
lesion is not observed at currents between 500 µA and 2,500 µA when the electrode is 
placed on the scalp.  In addition, the area of brain lesion is higher in tissue sections 
located under the electrode and the degree at which lesion is induced depends on the 
amount of current injected.  Translationally, our rat model with the electrode placed on 
the skin suggests human tDCS models are well within the lesion safety limits, with 
human tDCS sessions generally using current densities well below (generally about 10 
A/m2 or less) our maximum current density tested (100 A/m2).  However, brain damage 
associated with functional changes at a molecular level during sub-lesion currents was 
not examined in this study and should be studied more extensively to gain a better 
understanding of tDCS as it relates to safety. 
Anodal tDCS Safety Limits in the Rat 
 Our results show brain lesion in rats can be induced with a 500 µA current, 
corresponding to a current density of 20 A/m2, and the volume of lesion increased as the 
current was increased (Fig. 3B), showing anodal tDCS at or above 500 µA for durations 
longer than 60 minutes will induce brain lesion in our rodent model.  Because the lesion 
noted in our study was relatively small at 500 µA, stimulating for durations less than 60 
minutes at 500 µA may not produce lesion and warrants further examination.  While most 
rat studies using skull electrodes typically do not stimulate for
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durations lasting longer than 30 minutes (Bolzoni, Baczyk, et al., 2013; Pedron et al., 
2014), our data can be a valuable guideline for future studies aimed at increasing the 
amount of current given to the rat to produce various biological effects. 
Current Localization and Brain Lesion  
The focality of tDCS in the brain can be seen by examining images of brain 
lesion.  Histological analysis (Fig. 1) shows lesion beginning in regions closest to the 
CSF and spreading laterally and penetrating deeper into the tissue as the current is 
increased, suggesting the concentration of current in the brain increased with the current.  
Translating to human tDCS, the current may be affecting the outer cortical layers more 
than other brain regions, and secondary effects are triggered in other brain regions.  
Interestingly, some human tDCS studies seem to provide evidence for this, as there is an 
enhanced benefit from tDCS by activating the brain regions during stimulation, such as 
when learning a coordinated movement (Zhu et al., 2015).  
Physiologically, our brain lesion is seen most in regions under the electrode (Fig. 
3), suggesting not only the highest concentrations of current in the brain are near the 
CSF, but that in addition the greatest concentration is in the CSF under the electrode.  
This can potentially be explained by considering electricity is able to flow in areas with a 
lower resistance and is less able to flow in areas that are more resistant, as is the case 
with a common wire; a low resistance metal is insulated by a high resistance rubber.  For 
tDCS, the conductance properties of four tissues are typically studied: the scalp, skull, 
CSF, and brain (Datta, Elwassif, & Bikson, 2009).  The skull is the least conductive 
material, while the scalp and CSF are the most conductive (Datta et al., 2009).   
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It can be inferred from our knowledge of current and conductance that as 
electrons move towards the anode via the CSF during anodal stimulation, their movement 
is impeded by the resistive properties of the skull, resulting in more electrons clustering 
under the electrode as they are not able to move as freely across the skull tissue.  The 
movement of electrons has not been shown in vivo, however, an increase in brain tissue 
pH during and after tDCS in humans has been shown in the area of stimulation (Rae, Lee, 
Ordidge, Alonzo, & Loo, 2013).  Rae et al., 2013 attributed the rise in pH to “activation 
of the creatine kinase system according to the reaction: Creatine + ATP ↔ PCr + ADP + 
H+”, where the extra proton is used to hydrolyze phosphocreatinine, resulting in an 
increased pH (Rae et al., 2013).  While their data does provide evidence of the creatine 
kinase system for the increased pH under the anode, it is also likely the rise in pH is in 
part due to increased electrons from the current during anodal tDCS stimulation. 
Effects of Electrode Placement on the Scalp and Skull 
While tDCS was able to induce lesion when the electrode was placed on the skull, 
there was no lesion present when the same tDCS current was used with the electrode 
placed on the scalp (Fig. 6).  This effect was expected, as computational studies have 
predicted the scalp shunts the delivery of electrical currents by as much as 50 % (Faria et 
al., 2011; Truong et al., 2013), and as much as 65% of the current when all tissues 
between the electrode and brain are considered (scalp, skull, CSF).  This study shows 
scalp shunting diverts enough current to prevent brain lesion at the highest stimulation 
intensity possible for our model, which was limited for both groups due to reaching 
maximum voltage limits.  Interestingly, 50% of our highest stimulation group (2500 µA) 
with a scalp electrode corresponds to 1250 µA, which is greater than two of the three 
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stimulation groups showing lesion with an electrode placed on the skull.  Additionally, 
65% of our highest stimulation corresponds to 875 µA, which is still higher than the 500 
µA lesion was first seen with a skull electrode, suggesting there may be other interactions 
involved in current shunting and warrants further study.   
It has been previously noted that many researchers study biological changes from 
tDCS using rodents by implanting an electrode on the skull, while researchers using 
humans study tDCS by placing the electrode on the scalp.  This study indirectly shows 
there are differences in the concentration of current reaching the brain in an animal model 
when the electrode is placed on the scalp, suggesting physiological differences resulting 
from tDCS with a skull implanted electrode may not translate when the electrode is 
placed on the scalp.  Why the current differs with an electrode placed on the scalp could 
be explained by considering the movement of electrons are following the path of least 
resistance.   
There have been no previous studies examining the differences in current flow 
between the two electrode placements, but a possibility is that during skull tDCS, the 
CSF provides the easiest path to the anode from the cathode because the anode is fixed 
onto the skull, whereas the scalp is the easiest pathway for the current and can get to the 
anode via the scalp tissue without having to cross between the resistive skull tissue 
(Figure 8).  If true, the different pathways each type of stimulation would explain the 
differences in brain lesion using the same current.  Notably, possible damage to the scalp 
during stimulation with an electrode placed on the scalp was not evaluated.  Additionally, 
at sub lesion currents, using an electrode implanted on the skull can be expected to have 
different effects on brain tissue than would be seen using a scalp electrode.  
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Figure 8: Proposed effect of electrode placement on electron movement during anodal 
tDCS.  A theoretical model predicting the flow of current during tDCS.  The black box in 
the figures represent an electrode implanted on the scalp (A) and placed on the skull (B).  
The arrows represent the predicted flow of most electrons during stimulation, with black 
arrows representing electron flow under the skull and blue arrows representing electron 
flow over the skull 
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Anodal and Cathodal tDCS Comparison 
Comparing our study of anodal tDCS safety with Liebetanz’s 2009 study of 
cathodal safety shows both similarities and differences between the currents.  First, a 
histological comparison (Figure 9) shows cathodal currents induce lesion in a focused, 
conical shape (Fig. 9B), whereas anodal currents produce lesion closer to the outer cortex 
and spread more laterally (Fig. 9A).  A reason for the difference could be 
methodological; our electrode was 25 mm2, while the electrode used in the Liebetanz et 
al study measured 3.5 mm2.  Another methodological issue is the electrode in our study 
was placed over the center of the brain, beginning at Bregma, during anodal tDCS, while 
the cathodal stimulation placed the electrode 1.5 mm rostral to Bregma and 1.5 mm to the 
right of the sagittal fissure. The electrode size and location do seem to prevent any 
meaningful comparison between our study and the Liebetanz study, but unpublished data 
using a smaller electrode of 5.31 mm2 2.5 mm caudal Bregma and 2.5 mm right of the 
sagittal fissure during anodal stimulation shows the same patterns of a more lateral and 
superficial lesion when compared to the lesion during cathodal stimulation.  
One possible explanation for the differences in lesion could be the deduced from 
our knowledge of the differences in the movement of current during anodal and cathodal 
stimulation.  The electrons during cathodal stimulation move from the skull to the CSF 
where the electron flows then moves towards the anode.  The anode in Liebtanz’s study 
was placed on the chest, pulling the current down through the brain toward the anode, 
causing the conical lesion.  During anodal stimulation, the electrons left the cathode and 
were being pulled towards the anode via the CSF, but were impeded possibly because the 
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anode was implanted on the skull, resulting in a buildup of electrons and a flatter lesion 
pattern.  
The increase in the amount of lesion present during anodal stimulation could have 
occurred due to an increase in the amount of current within the brain.  Because anodal 
stimulation moves electrons to the anode, most electrons could be predicted to move 
through the brain before reaching the anode.  Conversely, during cathodal stimulation, 
electrons could travel to the anode in tissues present before reaching the brain.  The 
above explanation of lesion formation is a prediction from our knowledge of anodal and 
cathodal currents, the veracity of which requires further examinination. 
 
Figure 9: Comparison of anodal (A) and cathodal (B) brain lesion.  Anodal brain lesion 
is more lateral compared to cathodal stimulation.  In addition, cathodal stimulation 
induced brain lesion that penetrated further into the cortex.  The image of anodal brain 
lesion was taken from our study at a stimulation of 2,500 µA, and the cathodal lesion 
image is from the Liebetanz et al. (2009) study at 1,000 µA. 
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Previously Proposed Mechanisms of Lesion 
Three proposed mechanisms of electrical stimulation responsible for inducing 
brain lesion have been proposed: (1) electrochemical production of toxic substances at 
the electrode, (2) extensive and high-frequency stimulations leading to excitotoxic firing 
rates, and (3) charge transfer through tissue leading to heating and thermal energy 
dissipation (Agnew & McCreery, 1987).  The Liebetanz et al. (2009) study provided 
sound reasoning for the damaging mechanism being joule heating rather than the two 
other mechanisms considered.   
While joule heating would ultimately seem to be involved in our model as well, 
our study did use anodal tDCS, so excitotoxic firing rates must also be considered.  tDCS 
has been shown to alter stimulated brain regions at subthreshold levels during tDCS 
(Nitsche & Paulus, 2000), but in our study, it is possible our higher stimulation groups 
were receiving suprathreshold currents because in vivo studies on how tDCS affects a 
rat’s brain have never previously been tested. If the rats in our study were receiving 
suprathreshold currents, then it is entirely possible some or all of the lesions seen is due 
to excitotoxic firing rates induced by tDCS.  However, joule heating could also be 
responsible for a significant portion of the brain lesion, so both excitotoxic firing rates 
and joule heating must be considered as potential, or concurrent, damage mechanisms in 
our model. 
Further Discussion of Proposed Lesion Mechanisms 
The Nitsche and Paulus (2000) experiments showed that anodal and cathodal 
tDCS leads to either an increase or decrease in resting potential, meaning anodal 
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stimulation increased the amount of millivolts during resting potential and cathodal 
stimulation decreased the amount of millivolts during resting potential at the region of the 
brain measured.  Voltage, known in electrophysics as electric potential energy, is the ratio 
of energy (measured in joules) per charge (measured in coulombs), meaning an increase 
in voltage signals an increase in the amount of energy present on one coulomb of 
electrons.  Conversely, a decrease in voltage signifies a decrease in the amount of energy 
for one coulomb.  This study was increasing the amount of energy per charge in the rat 
brain through anodal tDCS, likely suprathreshold at higher, lesion producing 
stimulations; interestingly, an extremely significant positive correlation between the total 
amount of joules produced from our stimulation and the amount of lesion induced (Figure 
10).   
The correlation data from this study, when considered from a Hodgkin and 
Huxley model of action potentials (where action potentials typically occur from 
increasing mV in a neuron), suggest the amount of energy given to the brain could be 
responsible for inducing both joule heating as well as excitotoxic firing rates to produce 
brain lesion in our animals.  One could also infer that the amount of energy given to the 
brain via tDCS could also be responsible for the beneficial effects seen in clinical and 
experimental studies as well.   
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Figure 10: Correlating Joules and Lesion Volume.  Lesion volume measurements were 
taken from animals in the 500 and 1,000 µA skull stimulation groups.  Correlation 
Coefficient = 0.974, P<0.001. 
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V.  CONCLUSION 
This study was conducted to test aspects of tDCS safety and methodology.  The 
first experiment was conducted to determine a safe anodal tDCS current with our 
electrode montage that could study physiological changes in learning and memory, and 
was necessary after visual signs of brain damage occurred at current densities lower than 
142.9 A/m2 determined by Liebetanz et al. 
Our results show brain lesion during a 60 minute anodal tDCS session begins at 
500 µA, and the amount of lesion increases as the current is increased.  The electrode 
used in our study had a surface area of 25 mm2, meaning our first lesion was seen at 20 
A/m2 with our anodal tDCS electrode montage, which is significantly lower than the 
previously determined lesion threshold of 142.9 A/m2.  Additionally, significant 
differences in areas of lesion in our study occurred under and in front of the electrode, 
with the lesion area spreading laterally and penetrating deeper into the tissue at higher 
stimulation intensities.  These differences could be due to utilizing different tDCS 
currents but warrant further study as this study was not intended to be a comparison with 
the Liebetanz et al. study. 
The second goal of this study was to test how the scalp tissue affects the 
concentration of current reaching the brain by comparing brain lesion from the first 
experiment to equal stimulation groups but with the anode placed on the scalp.  
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Computational models predict the scalp tissue will shunt a portion of the current, 
resulting in a decreased concentration of current reaching the brain.   
None of the stimulation groups using a scalp electrode showed brain lesion, 
suggesting a portion of the current was shunted when the electrode was placed on the 
scalp; the decreased lesion is in agreement with computational models.  Additionally, 
differences in brain lesion between the skull and scalp electrodes could be due to 
differences in how the electrons flow to the anode.  Lastly, a correlational figure between 
joules produced as a result of tDCS and brain lesion induced was shown, suggesting 
joules could be responsible for inducing brain lesion and may be a more reliable method 
of discussing tDCS dosing. 
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